Kathryn Regan, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13619 Midfield Glen Ct, Houston, TX 77059 Phone: 323-397-3390 |
Esther C Aludogbu, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 4250 Cook Rd, Houston, TX 77072 Phone: 323-518-8890 |
Sarah Virginia Blasius Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1010 Heights Blvd, Houston, TX 77008 Phone: 586-651-5118 |
Carol Beth Gustafson, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2002 Holcombe Blvd, Rm 2a-120, Houston, TX 77030 Phone: 713-794-7112 |
Mrs. Pamela Levy Diebner, M.S., Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5430 Imogene St, Houston, TX 77096 Phone: 713-662-9085 |
Anica Ibarguen, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12605 East Fwy Ste 212, Houston, TX 77015 Phone: 713-453-0400 Fax: 713-453-0408 |
Mrs. Deadrien Hudson Brown, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6109 Maple St, Houston, TX 77074 Phone: 713-668-6690 |
Ms. Stacy D. Gant, M. ED., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1714 Redwing Ridge Dr, Houston, TX 77009 Phone: 713-858-9999 Fax: 713-868-2763 |
Kelsey Brown, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3207 Lakeside Trl, Houston, TX 77077 Phone: 713-835-5325 Fax: 832-900-1112 |
Jessica Garza Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12605 East Fwy, Suite 212, Houston, TX 77015 Phone: 713-453-0400 |
Sayuri Morales Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2900 Woodridge Dr Ste 300, Houston, TX 77087 Phone: 713-741-5800 |
Janice Kay Jones, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11902 Resource Pkwy, Houston, TX 77089 Phone: 281-922-6802 Fax: 281-922-6802 |
Melanie Yvonne Evans, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3603 Chenevert St Apt 308, Houston, TX 77004 Phone: 918-231-0534 |
Caitlyn Pratt Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2900 Woodridge Dr Ste 300, Houston, TX 77087 Phone: 713-741-5800 |
Ashley Fritcher Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10300 Jones Rd, Houston, TX 77065 Phone: 281-897-4000 |
Jennifer Smith, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8390 Westview Dr, Houston, TX 77055 Phone: 713-251-7500 |
Judianne Woods, M.A., SLP-INTERN Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2180 North Loop W Ste 160, Houston, TX 77018 Phone: 832-831-0043 Fax: 832-200-2266 |
Patricia Mccoy, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1313 Campbell Rd Ste B1, Houston, TX 77055 Phone: 713-468-0300 Fax: 713-468-0336 |
Mrs. Angela Galatas, MA CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7900 Fannin St, Ste. 1800, Houston, TX 77054 Phone: 713-791-9363 Fax: 713-795-0488 |
Mrs. Dawn Young Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8524 Highway 6 N, 247, Houston, TX 77095 Phone: 225-270-8096 |
News Archive
The covid-19 pandemic has shone a spotlight on public health, a key part of the health care system that usually operates in the background.
Eventus Diagnostics, Inc. today announced that it has received CE mark designation for its Octava Pink™ breast cancer test intended for confirmatory use in women who have received negative mammography results.
A research team headed by investigators at the Icahn School of Medicine at Mount Sinai has developed a tool that allows scientists to quickly manipulate levels of two proteins in the same cell.
Millennium Laboratories, a leading provider of therapeutic drug monitoring and education to physicians and staff treating chronic pain patients, announced today the company's development and validation of a clinical quantitative assay for the new drug tapentadol (Nucynta™) by liquid chromatography/tandem mass spectrometry (LC-MS/MS).
A new predictive marker which could help doctors to decide whether breast cancer patients would benefit from chemotherapy has been identified by a team of scientists. The study, part-funded by Cancer Research UK and published in the British Journal of Cancer today (Wednesday), shows for the first time how this molecular marker has been singled out as an independent factor in examining a breast cancer patient's tumour.
› Verified 3 days ago